Biosample Hub

Our web platform offers various resources, such as noticeboards, directories, and communication tools. It enables direct interaction between biorepository managers and biotech professionals. For example, members can search directories or post biosample requests. Additionally, our admin support is always ready to assist with operational needs.

iosample Hub connects providers and requesters of patient samples from across the globe. Our members include professionals from North and South America, Europe (mainly Western Europe), the Middle East, Africa, Asia, and Australasia. Notably, Biosample Hub operates as a not-for-profit company registered in the UK, which helps ensure that ethical practices are upheld.

Resources in other languages

• French
• German
• Italian
• Portuguese
• Spanish

Biosample Hub operates as a not-for-profit organization, which aligns with the non-commercial biorepositories we serve. Consequently, users can trust that our platform maintains high ethical standards throughout.

We prioritize transparency in all interactions between biorepositories and biosample requesters. Furthermore, our financial records are publicly available, ensuring complete transparency in our operations.

Our mission is to connect non-commercial biorepositories with biotech and pharma companies. By doing so, we support the development of new therapies, diagnostics, and vaccines.

Biosample Hub operates online, serving a global community. Our members come from North and South America, Europe, the Middle East, Asia, and Australasia. The company is registered in the UK.

There are compelling reasons to organize patient sample procurement on a non-commercial basis. For more details, refer to the Nuffield Council on BioEthics report entitled ‘Human tissue: ethical and legal issues’ (pages 50 to 53). Commercial interests can often reduce sample traceability, leading to ethical and scientific concerns (Hofman et al, 2017).

Prospective collection begins only after a request is placed, which is necessary for obtaining fresh viable tissue or when the required biosamples are not available in the biobank. Importantly, requesters can specify:

• Sample types to be collected
• Biosample collection protocols to be used

Learn about prospective collection

Researchers commonly use FFPE, which stands for formalin-fixed paraffin-embedded tissue blocks, in diagnostics and medical research.

Learn about FFPE

A Material Transfer Agreement is a legal contract that governs the transfer of tangible research materials between two organizations, often between academic institutions, research organizations, or companies. It outlines the terms and conditions under which the recipient can use the materials. MTAs are commonly used in scientific research and development, especially in fields like biotechnology, pharmaceuticals, and life sciences.

Learn about Material Transfer Agreements

Yes, an increasing number of biobanks on our network will provide patient derived organoids (PDOs).

Learn about Patient Derived Organoids